References
- Wallis R. Structural and functional aspects of complement activation by mannose-binding protein. Immunobiology 2002;205:433–45.
- Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003;37:1496–505.
- Kruse C, Rosgaard A, Steffensen R, Varming K, Jensenius JC, Christiansen OB. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol 2002;187:1313–20.
- Hellemann D, Larsson A, Madsen HO, Bonde J, Jarlov JO, Wiis J, Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum Mol Genet 2007;16:3071–80.
- Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun 2006;7:393–400.
- Sebastiani P, Abad MM, Alpargu G, Ramoni MF. Robust transmission/disequilibrium test for incomplete family genotypes. Genetics 2004;168:2329–37.
- Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000;241:33–42.
- Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, Chanock SJ. Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun 2004;5:461–76.
- Imboden M, Swan H, Denjoy I, Van Langen IM, Latinen-Forsblom PJ, Napolitano C, Female predominance and transmission distortion in the long-QT syndrome. N Engl J Med 2006;355:2744–51.